Top Industry News
- FDA Postmarketing Studies and Clinical Trials: Determining Good Cause for Noncompliance with Section 505(o)(3)(E)(ii) of the Federal Food, Drug, and Cosmetic Act
- MHRA Register of Brokers Authorised to Deal in Human Medicines
- PMDA ICH E6 (R3) “Good Clinical Practice for Pharmaceuticals” Guideline Draft Briefing Session
- Malaysia’s NPRA Publishes Guideline on Nitrosamine Impurities
- Pakistan’s DRAP Seeks Feedback on Draft Guidelines for Post-Registration Variation of Drugs
- PMDA FY2023 Safety Information for Drugs and Medical Devices
- MHRA Register Medical Devices to Place on the Market
- FSANZ Calls for Public Input on Proposed Changes to Marine Biotoxin Levels in Bivalve Molluscs
- EFSA's Safety Evaluation of Genetically Modified Saccharomyces Cerevisiae Strain LALL-LI's Food Enzyme Triacylglycerol Lipase
- EU Safety Gate: the EU Rapid Alert System for Dangerous Non-Food Products - Crema Solare Viso & Corpo
- Health Canada's Announcement: Putting an End to Cosmetic Animal Testing in Canada